Monday, June 16, 2025

Latest

Harvest Health: Canaccord Reiterates Price Target Following Earnings

On August 10, Harvest Health and Recreation (CSE: HARV) reported its second quarter results. The company reported revenues of $102.5 million, up 15% sequentially and beating even the streets highest estimate. Gross profit came in at $52.3 million with a 51% profit margin, while adjusted EBITDA was $28 million. The company also reiterated its $400 million revenue guidance for 2021.

Analysts have a consensus C$7.00 12-month price target on the company, via a total of 4 analysts, with one analyst having a strong buy rating, and the other 3 analysts have buy ratings. The street high comes from Alliance Global Partners with a C$9.50 price target, and the lowest target comes from Stifel-GMP with a C$5.50 price target.

Canaccord Genuity reiterated their buy rating and C$8 price target on the stock, saying that the top line was a beat but margins took a step backward. Harvest’s top-line came in higher than the $96.3 million estimate but barely missed the $52.5 million gross margin estimate.

For other line items, Canaccord’s G&A estimate was $26.5 million, about $6.8 million lower than actual. Canaccord says the beat mainly came from the legalized Arizona market and 5 new Florida stores.

Canaccord believes that the $400 million revenue guidance is reasonable and “likely on the low end.” They are also happy with what Steve White had to say on the call around the Trulieve acquisition, saying, “Trulieve and Harvest have commenced integration planning activities and have begun working to secure all necessary regulatory approvals for change of ownership.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Silver: The Santa Elena Mine

Equinox Gold: Guidance Cut After Issues At Greenstone

Simply Solventless Q4 Earnings: So Much For Guidance

Recommended

NexGen Energy Receives Approval For Site Expansion At Rook I Project

ESGold Sees Installation Of Humphrey Spirals Completed At Montauban

Related News

Alamos Gold Sees Canaccord Lift Rating To Buy After Q1 Results

This past week Alamos Gold Inc. (TSX: AGI) reported its first quarter financial results. The...

Saturday, April 30, 2022, 01:16:00 PM

Cresco Labs: Canaccord Bumps Price Target Up To $20.50

Wednesday, Canaccord came out with their updated valuations for the large three multi-state operators. With...

Sunday, January 17, 2021, 01:41:00 PM

Cineplex: Canaccord Lifts Price Target To $18 On Improving Outlook

On May 13, Cineplex Inc. (TSX: CGX) reported its first quarter financial results. The company...

Friday, May 20, 2022, 04:07:00 PM

Teladoc: Mixed Results From Analysts Following Q4 Results

On February 24th, Teladoc Health (NYSE: TDOC) reported their full-year and fourth quarter results. Fourth...

Friday, February 26, 2021, 04:06:40 PM

Well Health: Canaccord Reiterates Ratings Following Recent Acquisition

Last week WELL Health Technologies (TSX: WELL) announced their latest acquisition, a majority stake in...

Friday, September 10, 2021, 03:29:00 PM